verdinexor (KPT-335) / Karyopharm, Anivive, Antengene  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
verdinexor (KPT-335) / Anivive, Antengene
NCT02431364: Trial of Safety and Tolerability of Oral Verdinexor (KPT-335) in Healthy Adults

Terminated
1
33
RoW
Verdinexor, KPT-335, Placebo
Karyopharm Therapeutics Inc
Healthy
10/15
10/15

Download Options